Blog
Scientists Discover Brain Chemical Linked to Trauma and Depression
- A groundbreaking study by researchers from Columbia University and McGill University has identified a brain protein, SGK1, that appears to play a key role in the development of depression and suicidal thoughts in individuals who experienced childhood trauma.
- The researchers found that elevated SGK1 levels are strongly associated with adults who endured physical abuse, neglect, or dysfunctional family environments during early life. This protein affects how the brain responds to stress and may serve as a biological trigger for depression. The findings are especially important because conventional antidepressants, such as SSRIs, are often less effective in patients with early-life trauma.
- The team is exploring new medications that inhibit SGK1 activity. Animal studies have shown promising results: mice treated with SGK1 inhibitors did not develop depressive behaviors even under chronic stress. This discovery could pave the way for personalized therapies aimed at helping trauma survivors at high risk of depression or suicide.
- Professor Christoph Anacker explains that SGK1 inhibitors could be quickly adapted for clinical use, as they are already being tested for other conditions like atrial fibrillation. Moreover, SGK1 could become a screening tool to identify the most vulnerable patients, offering hope for targeted and effective treatments.
